Ligand · 3MI
3MI · 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
3MI, 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid (C14 H7 Cl2 N O3, 308.1 g/mol), in the MolNFT structures on GenesisL1: bound in 8 records (5 PDB entries). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- 3MI
- Formula
- C14 H7 Cl2 N O3
- Class
- ligand
- Structures
- 8
- PDB entries
- 5
Binding sites
3MI in 8 structures; the first of them:
- 6E72 · Structure of Human Transthyretin Val30Met Mutant in Complex with Tafamidis · 3MI A201 · binds LYS15, LEU17, ALA108, ALA109, LEU110, SER117, THR118, THR119
- 6E74 · Structure of Human Transthyretin Leu55Pro Mutant in Complex with Tafamidis · 3MI A201 · binds LYS15, LEU17, ALA108, ALA109, LEU110, SER117, THR118, THR119
- 6FFT · Neutron structure of human transthyretin (TTR) S52P mutant in complex with tafamidis at… · 3MI A201 · binds LYS15, LEU17, ALA108, LEU110, SER117, THR118, THR119
- 6E6Z · Structure of wild type human transthyretin in complex with tafamidis · 3MI A201 · binds LYS15, LEU17, ALA108, SER117, THR118, THR119
- 6E72 · Structure of human transthyretin VAL30MET mutant in complex with tafamidis · 3MI A201 · binds LYS15, LEU17, ALA108, LEU110, SER117, THR118, THR119
- 6E74 · Structure of human transthyretin LEU55PRO mutant in complex with tafamidis · 3MI A201 · binds LEU17, ALA108, LEU110, SER117, THR118, THR119
- 6E77 · Structure of human transthyretin ASP38ALA mutant in complex with tafamidis · 3MI A201 · binds LYS15, LEU17, ALA108, LEU110, SER117, THR118, THR119
- 6FFT · Neutron structure of human transthyretin (ttr) S52P mutant in complex with tafamidis at… · 3MI A201 · binds LYS15, LEU17, ALA108, SER117, THR118, THR119
Residues it binds most
THR 16, LEU 16, ALA 16, SER 16, LYS 15, MET 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.